![]() |
市場調查報告書
商品編碼
1822408
腸腦營養市場預測(至 2032 年):按產品類型、形式、應用、最終用戶和地區進行的全球分析Gut-Brain Axis Nutrition Market Forecasts to 2032 - Global Analysis By Product, Type, Form, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球腸腦營養市場預計在 2025 年達到 14 億美元,到 2032 年將達到 35 億美元,預測期內的複合年成長率為 13.5%。
腸腦營養是指富含纖維的食物和補充劑,例如益生元、益生菌、水果、蔬菜和發酵產品,它們有助於維持腸道健康與大腦功能之間的關聯。這些營養豐富的選擇不含人工添加劑,能夠促進健康的微生物群落、清晰的思維和健康的情緒。這些產品專為注重健康的消費者設計,透過均衡、有益腸道健康的飲食,提供天然的解決方案,增強消化系統和認知健康。
根據《營養學前沿》報道,該市場專注於益生菌和益生元,旨在透過調節腸道微生物群來改善心理健康。
提高心理健康意識
這一市場的發展得益於公眾心理健康意識的顯著提升以及對腸腦關係理解的不斷加深。消費者正在超越傳統方法,透過飲食積極管理壓力、焦慮和認知功能。科學檢驗表明,微生物群落如何透過迷走神經和神經傳導物質的產生影響情緒和大腦健康,這鼓勵人們尋求營養解決方案,而腸腦產品正成為實現整體心理健康的針對性策略。
腸道菌叢的複雜性
一個主要障礙是人體腸道微生物群的高度複雜性和個體差異性。由於每個人的微生物組成都是獨一無二的,受飲食、遺傳和環境的影響,千篇一律的營養方法往往無法產生一致的效果。這種複雜性使得公司難以做出普遍有效的功效宣傳,而當產品未能達到預期效果時,也可能導致消費者產生懷疑。
個人化營養和膳食計劃
基於個體微生物組分析制定個人化營養計畫蘊含著巨大的商機。腸道微生物組檢測(例如糞便樣本檢測試劑套件)的進步將使企業能夠針對特定的益生菌、益生元和旨在糾正個體與心理健康相關的獨特微生物失衡的食品提供個人化建議。這種數據主導製化方法能夠帶來巨大的價值,證明溢價的合理性,提高療效,並從通用解決方案轉向有針對性的干涉措施。
誤導性行銷和虛假宣傳
市場面臨嚴重的威脅,例如誤導性行銷和誇大其詞的健康聲明,這些聲明缺乏堅實的臨床證據支持。一些品牌過度宣傳其對複雜精神疾病的療效,這有可能招致消費者失望和監管機構的強烈反對。這種「洗白」行為可能會削弱人們對整個產業的信任,引發美國食品藥物管理局 (FDA) 和歐洲食品安全局 (EFSA) 等機構的加強監管,最終導致消費者混淆,並損害合法科學的信譽,從而減緩市場成長。
新冠疫情帶來了顯著的正面影響,倍增了消費者對整體健康、免疫力以及應對疫情相關壓力和焦慮的興趣。這段時期,心理健康的重要性凸顯,人們對預防性自然療法的興趣也日益濃厚。居家時間的增加也促進了飲食實驗和關於腸腦關係的線上研究,將這些概念引入大眾,並使其成為持久的營養趨勢。
預計機能性食品市場在預測期內將佔據最大佔有率
機能性食品因其便利性、熟悉度以及易於融入日常飲食的特點,預計在預測期內將佔據最大的市場佔有率。消費者更傾向於從日常食品中獲取益處,例如發酵食品(優格、Kefir)、富含纖維的零食和強化食品,而非藥丸。由於此類食品降低了進入門檻,支持長期堅持,並有利於既定的飲食習慣,機能性食品很可能佔據最大的市場佔有率,使其成為向廣大消費者提供腸腦營養最便捷、最具商業性可擴展性的途徑。
預計益生菌部分在預測期內將以最高的複合年成長率成長。
益生菌細分市場預計將在預測期內實現最高成長率,這得益於積極的科學研究和消費者教育,這些研究和教育將特定益生菌菌株與心理健康益處(精神益生菌)直接聯繫起來。臨床證明,瑞士乳桿菌和長雙歧桿菌等菌株可以減輕壓力並改善情緒。隨著證據的增多,消費者正在積極尋求補充劑和強化雙叉桿菌中的這些目標菌株,從而推動創新和優質化。這些目標益處使益生菌成為市場上最具活力和高成長的成分之一。
預計亞太地區將在預測期內佔據最大的市場佔有率,這得益於其深厚的文化歷史,即飲食與整體健康息息相關,例如傳統中醫和阿育吠陀。機能性食品正逐漸獲得消費者對身心健康的認可。龐大的人口、不斷成長的可支配收入以及泡菜、味噌和康普茶等發酵食品的大量消費量,造就了一個成熟且接受度高的市場,使亞太地區成為腸腦營養產品最大的收益來源。
在預測期內,北美預計將出現最高的複合年成長率,這得益於注重健康的消費者群體、對個人化營養的強勁需求以及健康趨勢的快速普及。高數位參與度正在推動腸腦連結的有效教育。該地區是創新中心,許多新興企業和知名品牌推出了針對性的心理生物補充劑和機能性食品。
According to Stratistics MRC, the Global Gut-Brain Axis Nutrition Market is accounted for $1.4 billion in 2025 and is expected to reach $3.5 billion by 2032 growing at a CAGR of 13.5% during the forecast period. Gut-brain axis nutrition refers to foods and supplements, such as prebiotics, probiotics, or fiber-rich items like fruits, vegetables, and fermented products, that support the connection between gut health and brain function. These nutrient-dense options, free from artificial additives, promote a healthy microbiome, mental clarity, and emotional well-being. Designed for health-conscious consumers, they offer natural solutions to enhance digestion and cognitive health through balanced, gut-friendly diets.
According to Frontiers in Nutrition, this market focuses on probiotics and prebiotics designed to improve mental well-being by modulating the gut microbiome.
Rising awareness of mental health
The market is driven by a significant increase in public awareness of mental health and a growing understanding of the gut-brain connection. Consumers are becoming proactive about managing stress, anxiety, and cognitive function through diet, moving beyond traditional approaches. Scientific validation showing how the microbiome influences mood and brain health via the vagus nerve and neurotransmitter production encourages people to seek nutritional solutions, making gut-brain axis products a targeted strategy for holistic mental wellness.
Complexity of the gut microbiome
A major restraint is the extreme complexity and individuality of the human gut microbiome. A one-size-fits-all nutritional approach often yields inconsistent results because each person's microbial composition is unique, influenced by diet, genetics, and environment. This complexity makes it difficult for companies to make universal efficacy claims, potentially leading to consumer skepticism when products don't deliver expected benefits, thereby hindering widespread trust and adoption without a more personalized approach.
Personalized nutrition and diet plans
A significant opportunity lies in the development of personalized nutrition plans based on individual microbiome analysis. Advances in gut microbiome testing (e.g., stool sample kits) allow companies to offer tailored recommendations for specific probiotics, prebiotics, and foods designed to correct a person's unique microbial imbalances linked to their mental well-being. This data-driven, customized approach adds tremendous value, justifies premium pricing, and increases efficacy, moving beyond generic solutions to targeted interventions.
Misleading marketing and false claims
The market faces a severe threat from misleading marketing and exaggerated health claims that are not fully backed by robust clinical evidence. Some brands may overpromise results for complex mental health conditions, risking consumer disappointment and regulatory backlash. This "gut-washing" can erode trust in the entire category, invite stricter regulations from bodies like the FDA and EFSA, and ultimately slow down market growth by confusing consumers and discrediting legitimate science.
The COVID-19 pandemic had a profoundly positive impact, sharply accelerating consumer focus on holistic health, immunity, and managing pandemic-related stress and anxiety. This period highlighted the importance of mental well-being, driving interest in preventative and natural approaches. Increased time at home led to more dietary experimentation and online research into the gut-brain connection, introducing these concepts to a mass audience and cementing them as a lasting trend in the nutrition landscape.
The functional foods segment is expected to be the largest during the forecast period
The functional foods segment is expected to account for the largest market share during the forecast period, owing to their convenience, familiarity, and ease of integration into daily diets. Consumers prefer obtaining benefits from everyday foods like fermented items (yogurt, kefir), fiber-rich snacks, and fortified products rather than pills. This format lowers the barrier to entry, supports long-term adherence, and leverages established eating habits, making functional foods the most accessible and commercially scalable way to deliver gut-brain axis nutrients to a broad consumer base, thus securing the largest share.
The probiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the probiotics segment is predicted to witness the highest growth rate, reinforced by intense scientific research and consumer education directly linking specific probiotic strains to mental health benefits (psychobiotics). Strains like Lactobacillus helveticus and Bifidobacterium longum are clinically shown to reduce stress and improve mood. As evidence grows, consumers actively seek out these targeted strains in supplements and fortified foods, driving innovation and premiumization. This targeted efficacy positions probiotics as the most dynamic and high-growth component within the market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, ascribed to a deep cultural history of connecting diet with holistic well-being, as seen in Traditional Chinese Medicine and Ayurveda. There is inherent consumer acceptance of functional foods for mental and physical health. A massive population, rising disposable income, and high consumption of fermented foods like kimchi, miso, and kombucha create a mature and receptive market, making APAC the largest revenue generator for gut-brain axis nutrition products.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with a highly health-conscious consumer base, strong demand for personalized nutrition, and a rapid adoption of wellness trends. High digital engagement facilitates effective education on the gut-brain connection. The region is a hub for innovation, with numerous startups and established brands launching targeted psychobiotic supplements and functional foods, supported by significant venture capital funding and a willingness to pay a premium for scientifically-backed mental wellness solutions, driving the fastest growth.
Key players in the market
Some of the key players in Gut-Brain Axis Nutrition Market include Nestle Health Science, Danone S.A., Abbott Laboratories, Procter & Gamble Co., Yakult Honsha Co., Ltd., Chr. Hansen Holding A/S, BASF SE, DuPont de Nemours, Inc., General Mills, Inc., Kerry Group plc, Unilever PLC, PepsiCo, Inc., Coca-Cola Company, Mars, Incorporated, Johnson & Johnson, and AbbVie Inc.
In July 2025, Nestle Health Science launched a new precision probiotic supplement, 'BrainBiome X', specifically formulated with a clinically studied strain of Bifidobacterium longum shown in company trials to support stress management and positive mood by modulating the gut-brain axis.
In May 2025, Danone S.A. introduced its first functional yogurt drink under the Activia brand, 'Activia Mind & Gut', which contains a unique probiotic blend, prebiotic fibers, and vitamins B6 and B12 to nourish the gut-brain connection and support emotional well-being.
In April 2025, Abbott Laboratories received regulatory approval for its new medical nutrition shake, 'Ensure NeuroBiome', designed for older adults. It combines a specific prebiotic fiber with DHA and other nutrients to target cognitive health and gut function through the microbiome.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.